Abstract

In this study, we describe an ordered formation of long- and very long-chain ceramide species in relation to the progression of B-cell receptor (BcR) triggering induced apoptosis. An early and caspase-independent increase in long-chain ceramide species, in which C(16)- ceramide predominated, was observed 6 h after BcR triggering. In contrast, very long-chain ceramide species were generated later, 12-24 h after BcR triggering. The formation of these very long-chain ceramide species, in which C(24)-ceramide predominated, required the activation of effector caspases. BcR-induced formation of long-chain ceramide species resulted in proteasomal activation and degradation of XIAP and subsequent activation of effector caspases, demonstrating an important cell-biological mechanism through which long-chain ceramides may be involved in the progression of BcR triggering induced apoptosis and subsequent formation of very long-chain ceramide species. BcR-induced activation of the proteasome was blocked with ISP-1/myriocin, a potent and selective inhibitor of serine palmitoyl transferase that catalyzes the first and rate-limiting step in the de novo formation of ceramide. Both ISP-1 and clasto-lactacystin beta-lactone, an irreversible inhibitor of the proteasome, prevented BcR cross-linking-induced XIAP degradation. Also, a mutant XIAP lacking the ubiquitin-ligating ring finger motif was completely resistant to proteasome-mediated degradation, and Ramos cells overexpressing XIAP became highly resistant to BcR cross-linking-induced activation of caspases. The formation of C(16)-ceramide in response to BcR cross-linking was found unaltered in XIAP overexpressing Ramos cells, whereas C(24)-ceramide formation was completely abolished. These results demonstrate how de novo generated long-chain ceramide species may be involved in the activation of downstream effector caspases and subsequent formation of very long-chain ceramide species. As such, these results provide novel and important insights into the significance of specific ceramide species in defined stages of apoptosis.

Highlights

  • In this study, we describe an ordered formation of long- and very long-chain ceramide species in relation to the progression of B-cell receptor (BcR) triggering induced apoptosis

  • The early increase at 6 h after BcR cross-linking of C16-ceramide is seen both by Diacylglycerol Kinase (DGK) analysis as an increase in the lower ceramide-1-P spot upon separation by TLC (Fig. 1B) and by tandem MS analysis (Fig. 1D)

  • We have previously shown that the increase in ceramide after BcR cross-linking results from activation of the de novo pathway of sphingolipid biosynthesis [5]

Read more

Summary

Introduction

We describe an ordered formation of long- and very long-chain ceramide species in relation to the progression of B-cell receptor (BcR) triggering induced apoptosis. BcR-induced formation of long-chain ceramide species resulted in proteasomal activation and degradation of XIAP and subsequent activation of effector caspases, demonstrating an important cell-biological mechanism through which longchain ceramides may be involved in the progression of BcR triggering induced apoptosis and subsequent formation of very long-chain ceramide species. BcR-induced activation of the proteasome was blocked with ISP-1/myriocin, a potent and selective inhibitor of serine palmitoyl transferase that catalyzes the first and rate-limiting step in the de novo formation of ceramide Both ISP-1 and clasto-lactacystin ␤-lactone, an irreversible inhibitor of the proteasome, prevented BcR crosslinking-induced XIAP degradation. The formation of C16-ceramide in response to BcR cross-linking was found unaltered in XIAP overexpressing Ramos cells, whereas C24-ceramide formation was completely abolished These results demonstrate how de novo generated long-chain ceramide species may be involved in the activation of downstream effector caspases and subsequent formation of very long-chain ceramide species. CH2F; APCI, atmospheric pressure chemical ionization; MS, mass spectrometry; XIAPwt, wild type XIAP; XIAP⌬R, RING-less XIAP; EGFP, enhanced green fluorescent protein; CLC, clasto-lactacystin ␤-lactone; XIAP, X-linked inhibitor of apoptosis; PARP, poly (ADPribose)polymerase; IRES, internal ribosome entry site; BIR, Baculovirus IAP repeat; sn, sphingomyelin

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call